Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition
Frontiers in Pharmacology · 03.08.2023 · 14
DOI: 10.3389/fphar.2023.1218059 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 03.08.2023. Verfasst von Peng Pi und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Sports Medicine and Rehabilitation, Beijing Sport University, Beijing, China. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 197 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
As the outbreak of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first broke out in Hubei Province, China, at the end of 2019. It has brought great challenges and harms to global public health. SARS-CoV-2 mainly affects the lungs and is mainly manifested as pulmonary disease. However, one of the biggest crises arises from the emergence of COVID-19-induced fibrosis. At present, there are still many questions about how COVID-19 induced pulmonary fibrosis (PF) occurs and how to treat and regulate its long-term effects. In addition, as an important process of fibrosis, the effect of COVID-19 on epithelial-mesenchymal transition (EMT) may be an important factor driving PF. This review summarizes the main pathogenesis and treatment mechanisms of COVID-19 related to PF. Starting with the basic mechanisms of PF, such as EMT, transforming growth factor-β (TGF-β), fibroblasts and myofibroblasts, inflammation, macrophages, innate lymphoid cells, matrix metalloproteinases and tissue inhibitors of metalloproteinases, hedgehog pathway as well as Notch signaling. Further, we highlight the importance of COVID-19-induced EMT in the process of PF and provide an overview of the related molecular mechanisms, which will facilitate future research to propose new clinical therapeutic solutions for the treatment of COVID-19-induced PF.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Sports Medicine and Rehabilitation, Beijing Sport University, Beijing, China.
- College of Physical Education and Health, East China Normal University, Shanghai, China.
- School of Sports Engineering, Beijing Sport University, Beijing, China.
Zitieren
APA
Pi, P., Zeng, Z., Zeng, L., Han, B., Bai, X., & Xu, S. (2023). Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1218059
Vancouver
Pi P, Zeng Z, Zeng L, Han B, Bai X, Xu S. Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1218059
BibTeX
@article{Pi2023,
author = {Pi, Peng and Zeng, Zhipeng and Zeng, Liqing and Han, Bing and Bai, Xizhe and Xu, Shousheng},
title = {Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1218059}
}
EUVIMED